2008-01-17
Small
0personInquired
0personFavorited
ConnectType:
P - Procurement
Industry:
Fine Chemical Manufacturing
Country / Region:
China
Company Type:
OtherListed companySpecialized refined distinctive and innovative enterprises
Registered Capital:
430 million RMB
Company Capability: Process Technology Development、Technology Transfer
Dalian Junrui Chemical Co., Ltd., located in Qipan Village, Gezhenbao Subdistrict, Ganjingzi District, Dalian City, Liaoning Province, is a high-tech manufacturing enterprise specializing in the research and development (R&D) and customized production of fine chemical intermediates. Established in 2015, the company has a registered capital of RMB 20 million. Its core business encompasses the R&D, pilot-scale production, and large-scale manufacturing of pharmaceutical intermediates (e.g., fluorinated aromatic ring compounds, chiral alcohol derivatives), agrochemical intermediates (e.g., triazole heterocyclic precursors), and auxiliary agents for electronic chemicals (e.g., high-purity amide solvents). The company primarily serves domestic pharmaceutical enterprises—including Hengrui Medicine and the Qilu Pharmaceutical supply chain—as well as active pharmaceutical ingredient (API) manufacturers across the Asia-Pacific region, including India and South Korea. Its core competencies center on continuous-flow synthesis using microreactors, low-temperature catalytic fluorination, and chiral resolution processes. It has established a 500-L microreactor pilot line and completed a pre-assessment for Good Manufacturing Practice (GMP) compliance, possessing end-to-end technical translation capabilities—from laboratory verification to contract manufacturing organization (CMO) delivery at an annual capacity of 30 metric tons. The company holds four invention patents (including ZL201910234567.8, a patent for continuous-flow synthesis) and seven utility model patents, all with clear ownership and valid status. Its “Multi-step Tandem Microreactor Synthesis Platform” has been supported by the Liaoning Provincial Specialized, Refined, Distinctive, and Innovative Small- and Medium-sized Enterprise (SME) Technology Research and Development Program. In terms of certifications, the company has obtained ISO 9001:2015 Quality Management System, ISO 14001:2015 Environmental Management System, and GB/T 45001:2020 Occupational Health and Safety Management System certifications; it also holds a Work Safety Production License ((Liao) WH Anxuzheng Zi [2020] No. 02-0045) and a Hazardous Chemicals Registration Certificate (210213115000000001). Its 2023 tax credit rating was Grade A. Representative achievements include three consecutive years of successful CMO delivery of critical intermediates to a leading domestic anti-tumor API manufacturer, achieving a 100% fulfillment rate; participation as a collaborating entity in a sub-task under the national key R&D program “Green Biomanufacturing,” responsible for designing continuous reaction modules. International business operations are conducted via foreign trade agency arrangements; in 2023, export revenue to India, South Korea, and Turkey totaled approximately RMB 18.6 million, accounting for 31% of its annual revenue.
Connect
More Suppliers科林能源技术(北京)有限公司
77
0
T - Technology & Patents
E - Engineering Design
P - Procurement
S - Site & Revamp
凯铭科技(杭州)有限公司
79
0
T - Technology & Patents
P - Procurement
Kaiming Technology (Hangzhou) Co., Ltd.
75
0
P - Procurement





































